HYBRID-ON
LIVE

Serial Number

99813264

Owner

ADVANCED RNA TECHNOLOGIES, LLC

Attorney

Maxim Voltchenko

First Use Date

Apr 27, 2026

Filing Date

May 9, 2026

Add to watchlist:

No watchlists yet
View on USPTO

HYBRID-ON Trademark

Serial Number: 99813264

HYBRID-ON is a trademark filed by ADVANCED RNA TECHNOLOGIES, LLC on May 9, 2026. The trademark is classified under Class 1 (Chemicals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

ADVANCED RNA TECHNOLOGIES, LLC

17 Briden Street, Suite 102
Worcester, MA 01609

Entity Type: 16

Trademark Details

Filing Date

May 9, 2026

Registration Date

Not Registered

First Use Anywhere

April 27, 2026

First Use in Commerce

April 27, 2026

Goods & Services

Scientific and medical research services, namely, development, validation, and performance of molecular and biochemical assays for detection, localization, and quantification of nucleic acid-based therapeutics and research-use nucleic acid compounds in biological samples and tissues for research, preclinical, nonclinical, and clinical study purposes in human and veterinary fields; bioanalytical testing services relating to pharmacokinetics, pharmacodynamics, biodistribution, toxicokinetics, and tissue exposure of nucleic acid–based compounds; laboratory analysis, evaluation, and reporting of data generated in connection with such studies; custom design and development of detection assays and related reagents for research use; assay validation services; scientific consultancy relating to assay development, bioanalytical strategies, and technology transfer in the field of nucleic acid–based therapeutics and research compounds; and licensing of scientific research assay technology

Chemical and biochemical reagents for scientific and medical research use, namely, nucleic acid probes, nucleic acids detection reagents, assay buffers, and diagnostic assay kits comprised primarily of reagents for detection, localization, and quantification of nucleic acid-based therapeutics and research-use nucleic acid compounds in biological samples and tissues, all for research use only in human and veterinary fields

Filing History

APPLICATION FILING RECEIPT MAILED
May 9, 2026 MAFR
NEW APPLICATION ENTERED
May 9, 2026 NWAP